OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. (2015). Mediterranean Journal of Hematology and Infectious Diseases, 7(1), e2015003. https://doi.org/10.4084/mjhid.2015.003